Market By Cgms Component Type, Cgms End-user, Cgms Demographics, Smbg Type, Smbg End-user And Smbg Application | Forecast 2019-2025
The market for continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) in Malaysia has been projected to grow in terms of revenue with a CAGR of 24.46% and 10.43% respectively, during the forecast period between 2019 and 2025, according to a research conducted by Triton.
The rise in the incidence of diabetes in the country is driving the Malaysia glucose monitoring system market. According to the WHO, in 2016, Malaysia has a diabetes prevalence rate of 9.8%, with 10.2% in males and 9.5% in females. And according to the International Diabetes Federation, in 2017, there were about 3.4 million cases of diabetes in Malaysia. Moreover, the increasing innovation in the glucose monitoring space is making the devices concise and more convenient. The introduction of these devices promises to make diabetes easier to manage, with a variety of new innovations arriving at a furious pace. The new semi-invasive, implant and non-invasive approaches are being developed, which are expected to fuel the growth of the market.
The market uptake of self-monitoring systems is relatively deficient in the majority of developing countries like Malaysia. The primary reason for patients’ reluctance is the cost associated with these devices, as in most of the countries, health insurance companies do not provide reimbursement. Furthermore, despite the availability of medical coverage, which in most cases covers some part of the blood glucose monitoring device cost, the overall cost of diabetes management is exceptionally high and in most cases unaffordable for an average diabetic patient. This has restricted the growth of the glucose monitoring system market in Malaysia.
Triton Market Research’s report on the Malaysia glucose monitoring system market provides in-depth insight and segmentation analysis of the market. The detailed analysis of the market includes the key buying criteria, PESTEL analysis, value chain analysis, healthcare in Malaysia, diabetic care technologies and the market attractiveness index. The segmentation analysis of the Malaysia glucose monitoring system market includes the market by CGMS component type, by CGMS end-user, by CGMS demographics, by SMBG type, by SMBG end-user and by SMBG application.
Major players engaged in the Malaysia glucose monitoring system market are Johnson & Johnson, Abbott Laboratories, Roche Diagnostics, B Braun Melsungen AG, Arkray Inc, Becton Dickinson and Company and Terumo.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MALAYSIA GLUCOSE MONITORING SYSTEM MARKET - SUMMARY
1.2.
MARKET DRIVING ASPECTS
1.3.
MARKET RESTRAINING ASPECTS
1.4. KEY PLAYERS
2.
MALAYSIA GLUCOSE MONITORING SYSTEM INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PESTEL ANALYSIS
2.2.1.
POLITICAL
2.2.2.
ECONOMICAL
2.2.3.
SOCIAL
2.2.4.
TECHNOLOGICAL
2.2.5.
LEGAL
2.2.6.
ENVIRONMENTAL
2.3. HEALTHCARE IN MALAYSIA
2.4. DIABETIC CARE TECHNOLOGIES
2.5. KEY BUYING CRITERIA
2.6. VALUE CHAIN ANALYSIS
2.7. MARKET ATTRACTIVENESS INDEX
3.
MALAYSIA GLUCOSE MONITORING SYSTEM MARKET - SEGMENTATION
3.1. BY CGMS COMPONENT TYPE (SENSORS, TRANSMITTER AND RECEIVERS, INTEGRATED INSULIN PUMPS)
3.2. BY CGMS END USER (HOME SETTINGS, DIAGNOSTICS AND CLINICAL, HOSPITAL)
3.3. BY CGMS DEMOGRAPHICS (ADULT POPULATION (>14YEARS), CHILD POPULATION (>14YEARS))
3.4. BY SMBG TYPE (TEST STRIPS, GLUCOSE METER, LANCETS)
3.5. BY SMBG END USER (HOME SETTINGS, CLINICAL, HOSPITAL)
3.6. BY SMBG APPLICATION (TYPE 1 DIABETES, TYPE 2 DIABETES, GESTATIONAL DIABETES)
4.
COMPETITIVE LANDSCAPE
4.1. ABBOTT
4.2. ARKRAY, INC.
4.3. B BRAUN MELSUNGEN AG
4.4. BECTON DICKINSON AND COMPANY
4.5. JOHNSON & JOHNSON
4.6. ROCHE DIAGNOSTICS
4.7. TERUMO
5.
RESEARCH METHODOLOGY & SCOPE
5.1. RESEARCH SCOPE & DELIVERABLES
5.1.1.
OBJECTIVES OF STUDY
5.1.2.
SCOPE OF STUDY
5.2. SOURCES OF DATA
5.2.1.
PRIMARY DATA SOURCES
5.2.2.
SECONDARY DATA SOURCES
5.3. RESEARCH METHODOLOGY
5.3.1.
EVALUATION OF PROPOSED MARKET
5.3.2.
IDENTIFICATION OF DATA SOURCES
5.3.3.
ASSESSMENT OF MARKET DETERMINANTS
5.3.4.
DATA COLLECTION
5.3.5.
DATA VALIDATION & ANALYSIS
TABLE 1 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET 2019-2025 ($ MILLION)
TABLE 2 AVERAGE
PRICES OF GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER IN MALAYSIA (US $)
TABLE 3 MALAYSIA
- COUNTRY SNAPSHOT
TABLE 4 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY CGMS COMPONENT TYPE 2019-2025 ($ MILLION)
TABLE 5 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY CGMS END-USER 2019-2025 ($ MILLION)
TABLE 6 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY CGMS DEMOGRAPHICS 2019-2025 ($ MILLION)
TABLE 7 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY SMBG TYPE 2019-2025 ($ MILLION)
TABLE 8 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY SMBG END-USER 2019-2025 ($ MILLION)
TABLE 9 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET BY SMBG APPLICATION 2019-2025 ($ MILLION)
FIGURE 1 MALAYSIA
GLUCOSE MONITORING SYSTEM MARKET 2019-2025 ($ MILLION)
FIGURE 2 MALAYSIA
SMBG SALES CHANNEL 2019-2025 ($ MILLION)
FIGURE 3 TECHNOLOGIES
IN DIABETIC CARE
FIGURE 4 VALUE
CHAIN ANALYSIS OF CGMS MARKET
FIGURE 5 MARKET
ATTRACTIVENESS INDEX